Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.20.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Series A Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance, Shares at Dec. 31, 2017 185 52 133,695,111      
Beginning Balance, Amount at Dec. 31, 2017 $ 1,340,566 $ 362,059 $ 133,695 $ 127,421,402 $ (119,724,656) $ 9,533,066
Cumulative effect of a change in accounting principle related to ASC 606, net of tax   (430,000) (430,000)
Shares issued directors, shares 1,098,100      
Shares issued to directors, value $ 1,097 142,903 144,000
Stock-based compensation expense related to employee stock options 6,404 6,404
Net income attributable to common stockholders (3,016,750) (3,016,750)
Ending Balance, Shares at Dec. 31, 2018 185 52 134,793,211      
Ending Balance, Amount at Dec. 31, 2018 $ 1,340,566 $ 362,059 $ 134,792 127,570,709 (123,171,406) 6,236,720
Shares issued directors, shares 1,197,280      
Shares issued to directors, value $ 1,198 130,802 132,000
Stock-based compensation expense related to employee stock options 7,262 7,262
Net income attributable to common stockholders (1,934,133) (1,934,133)
Ending Balance, Shares at Dec. 31, 2019 185 52 135,990,491 135,990    
Ending Balance, Amount at Dec. 31, 2019 $ 1,340,566 $ 362,059 $ 135,990 $ 127,708,773 $ (125,105,539) $ 4,441,849